Loading data
BMEANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 61.98 m USD | 118.09 m USD | 102.55 m USD | 62.71 m USD | 28 m USD |
| Operating profit | -83.51 m USD | -144.07 m USD | -126.14 m USD | -83.63 m USD | -41.67 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -61.8 m USD | -138.43 m USD | -117.26 m USD | -81.83 m USD | -41.57 m USD |
| Basic earnings per share | -1.18 USD/share | -3.83 USD/share | -3.44 USD/share | -2.8 USD/share | -1.74 USD/share |
| Diluted earnings per share | -1.18 USD/share | -3.83 USD/share | -3.44 USD/share | -2.8 USD/share | -1.74 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.